N Verses Capital, LLC Tg Therapeutics, Inc. Transaction History
N Verses Capital, LLC
- $41.7 Billion
- Q1 2024
A detailed history of N Verses Capital, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 4,300 shares of TGTX stock, worth $84,193. This represents 0.16% of its overall portfolio holdings.
Number of Shares
4,300Holding current value
$84,193% of portfolio
0.16%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
273Shares Held
88.1MCall Options Held
2.72MPut Options Held
1.74M-
Vanguard Group Inc Valley Forge, PA13.5MShares$265 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.8MShares$212 Million0.0% of portfolio
-
State Street Corp Boston, MA7.8MShares$153 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.48MShares$68.2 Million0.02% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.33MShares$65.1 Million0.06% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $2.84B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...